Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard F. Ambinder

Showing results (11-20 of 218) with videos related to

Pageof 22
Sort By:
Critical Reviews in Oncology/Hematology|November 21, 2007
Immunotherapies for Hodgkin's lymphomaYvette L Kasamon, Richard F Ambinder
Blood|June 4, 2011
When differentiation goes viralCourtney M Shirley, Richard F Ambinder
Hematology/Oncology Clinics of North America|August 9, 2005
AIDS-related primary central nervous system lymphomaYvette L Kasamon, Richard F Ambinder
Current Opinion in Oncology|February 7, 2013
Hematopoietic stem cell transplantation in HIV-1-infected individuals: clinical challenges and the potential for viral eradicationChristine M Durand, Richard F Ambinder
Science (New York, N.Y.)|April 18, 2024
Sir Michael Anthony Epstein (1921-2024)Richard F Ambinder, Rena R Xian
Current Hematologic Malignancy Reports|April 29, 2010
Epstein-Barr virus-related lymphoproliferative disordersNina D Wagner-Johnston, Richard F Ambinder
Current Opinion in Oncology|February 28, 2008
Blood and marrow transplant for lymphoma patients with HIV/AIDSNina D Wagner-Johnston, Richard F Ambinder
Hematology. American Society of Hematology. Education Program|November 10, 2001
Viral Disease in HematologyGenoveffa Franchini, Richard F. Ambinder, Michèle Barry
Current Opinion in Oncology|July 23, 2013
Insights into the broad cellular effects of nelfinavir and the HIV protease inhibitors supporting their role in cancer treatment and preventionSoren Gantt, Corey Casper, Richard F Ambinder
Hematology. American Society of Hematology. Education Program|November 25, 2004
Hodgkin's lymphoma: evolving concepts with implications for practiceRalph M Meyer, Richard F Ambinder, Sigrid Stroobants
Pageof 22

Showing results (11-20 of 218) with videos related to

Sort By:
Pageof 22
Critical Reviews in Oncology/Hematology|November 21, 2007
Immunotherapies for Hodgkin's lymphomaYvette L Kasamon, Richard F Ambinder
Blood|June 4, 2011
When differentiation goes viralCourtney M Shirley, Richard F Ambinder
Hematology/Oncology Clinics of North America|August 9, 2005
AIDS-related primary central nervous system lymphomaYvette L Kasamon, Richard F Ambinder
Current Opinion in Oncology|February 7, 2013
Hematopoietic stem cell transplantation in HIV-1-infected individuals: clinical challenges and the potential for viral eradicationChristine M Durand, Richard F Ambinder
Science (New York, N.Y.)|April 18, 2024
Sir Michael Anthony Epstein (1921-2024)Richard F Ambinder, Rena R Xian
Current Hematologic Malignancy Reports|April 29, 2010
Epstein-Barr virus-related lymphoproliferative disordersNina D Wagner-Johnston, Richard F Ambinder
Current Opinion in Oncology|February 28, 2008
Blood and marrow transplant for lymphoma patients with HIV/AIDSNina D Wagner-Johnston, Richard F Ambinder
Hematology. American Society of Hematology. Education Program|November 10, 2001
Viral Disease in HematologyGenoveffa Franchini, Richard F. Ambinder, Michèle Barry
Current Opinion in Oncology|July 23, 2013
Insights into the broad cellular effects of nelfinavir and the HIV protease inhibitors supporting their role in cancer treatment and preventionSoren Gantt, Corey Casper, Richard F Ambinder
Hematology. American Society of Hematology. Education Program|November 25, 2004
Hodgkin's lymphoma: evolving concepts with implications for practiceRalph M Meyer, Richard F Ambinder, Sigrid Stroobants
Pageof 22